Senores Pharmaceuticals Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting

Senores Pharma's board approved Q4FY26 consolidated PAT up 104% to Rs 37 Cr & FY26 PAT up 108% to Rs 122 Cr. Key moves include Zoraya/Apnar acquisitions & US federal market JV. The Company Secretary resigned; a new Internal Auditor was appointed. #SenoresPharma #Earnings